Drug Testing Locations - Nashua, NH

Drug Testing in Nashua, NH

Nashua, New Hampshire Statistics

In 2022, Hillsborough County reported over 300 drug-related arrests in Nashua, NH.

Nashua, NH witnessed a 12% increase in opioid overdoses between 2021 and 2022.

Approximately 15% of Nashua residents struggle with some form of substance abuse, based on a 2023 survey.

In 2023, Nashua hospitals treated over 200 cases of drug overdoses, as reported in Hillsborough County.

In a 2022 report, Nashua, a city in Hillsborough County, NH, was found to have one of the highest rates of substance abuse in the state.

Nashua Police Department reported a 10% increase in heroin related incidents in 2023.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Nashua, NH & Drug Testing Policies

In Nashua, NH, employers play a crucial role in maintaining drug-free workplaces. Many local companies have implemented drug testing policies to prevent workplace incidents related to substance abuse. Typically, pre-employment screenings are mandatory, and random drug testing may be conducted to ensure ongoing compliance. The U.S. Department of Labor provides guidelines that employers in Nashua and across New Hampshire can follow to implement effective drug testing policies.

Additionally, Nashua employers may offer Employee Assistance Programs (EAPs) to support employees struggling with substance abuse. These programs are designed to provide confidential counseling and referral services, helping individuals access the resources they need to overcome drug-related challenges and maintain their employment. Resources from the Substance Abuse and Mental Health Services Administration are often used to enhance such workplace initiatives.

Government Efforts with Drug Problems in Nashua, NH

The city of Nashua, NH, within Hillsborough County, has implemented several government initiatives to address its drug problems. These include various public awareness campaigns and community-based intervention programs. For instance, the Nashua Prevention Coalition collaborates with local schools and organizations to combat substance abuse through education and outreach. Additionally, the state government has allocated grants to enhance local treatment facilities and improve accessibility to addiction services.

At the state level, New Hampshire's Department of Health and Human Services provides resources for residents seeking help for substance use disorders, offering support for both preventative and recovery efforts. Federally, the Office of National Drug Control Policy continues to support Nashua and Hillsborough County through funding and programs designed to reduce the impact of drugs in the community.

Local Drug Busts & News in Nashua, NH

Local law enforcement agencies in Nashua, NH have recently intensified their efforts to combat the drug trade, resulting in a significant drug bust earlier this month. Authorities reported the seizure of a substantial quantity of opioids and other illegal substances, leading to multiple arrests. This operation is part of a broader initiative to reduce drug-related crime and its impact on the community.

In another event, police uncovered an illegal drug manufacturing operation hidden in a residential area. The discovery was made following a tip-off from vigilant neighbors who noticed unusual activity around the property. This successful raid reflects the ongoing commitment of Nashua's police department to dismantle drug networks and ensure public safety.

Meanwhile, community outreach programs are being strengthened to tackle drug abuse at its roots. Nashua's public health officials are collaborating with schools and local organizations to educate residents, particularly the youth, about the dangers of drug use. These initiatives aim to prevent addiction and encourage individuals to seek help, thereby reducing demand for illicit drugs.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Nashua, NH. Trusted by employers nationwide for accurate results and exceptional service.

New Hampshire DOT/Non DOT Physicals

New Hampshire Vision Tests

New Hampshire Audiograms

New Hampshire Respirator Fit Tests

New Hampshire Lift Tests

New Hampshire Background Checks

Clinical Testing Services

TB Testing in NH

Diabetes Testing in NH

Infectious Disease Testing in NH

Sickle Cell Anemia Testing in NH

Women/Men's Health Testing in NH

Resources & Citations

Recovery Friendly Workplace NH

Dartmouth-Hitchcock Substance Use Services

Granite Pathways

NAMI New Hampshire

The Youth Council

Bedford Alcohol and Drug Treatment Center

New Hampshire Family Ties

NH Center for Excellence

Farnum Center

Revive Recovery Center

Drug Testing Near Nashua, NH

Derry, NH

Amherst, NH

Milford, NH

Windham, NH

Londonderry, NH

Hooksett, NH

Pelham, NH

East Merrimack, NH

Hollis, NH

Litchfield, NH

Hudson, NH

Frequently Asked Questions

Customer Reviews